Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Glycinebetaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | BBOX1 | O75936 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.33 |
| ▸ | CPT2 | P23786 | 1/20 | 0.31 |
| ▸ | CPT1A | P50416 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycinebetaine SCHEMBL665485 | 0.82 | TSHR (0.46) | BBOX1TSHRALDH1A1LMNAAPEX1 | |
| Glycinebetaine SCHEMBL4599013 | 0.80 | BBOX1 (0.42) | BBOX1TSHRALDH1A1LMNAAPEX1 | |
| Glycinebetaine SCHEMBL2803780 | 0.79 | TSHR (0.53) | BBOX1TSHRALDH1A1LMNAAPEX1 | |
| Glycinebetaine SCHEMBL8678519 | 0.79 | TSHR (0.53) | BBOX1TSHRALDH1A1LMNAAPEX1 | |
| Glycinebetaine SCHEMBL4900209 | 0.79 | — | — | |
| Betaine SCHEMBL31467313 | 0.79 | — | — | |
| Glycinebetaine SCHEMBL7739 | 0.79 | — | — | |
| Glycinebetaine SCHEMBL1580653 | 0.79 | BBOX1 (0.40) | BBOX1SMN1; SMN2TSHRALDH1A1LMNA | |
| Glycinebetaine SCHEMBL1138405 | 0.77 | DNM1 (0.54) | MAPTBBOX1KDM4ETSHRALDH1A1 | |
| Glycinebetaine SCHEMBL7996911 | 0.77 | DNM1 (0.54) | MAPTBBOX1KDM4ETSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220177949-A1 | METHODS OF RNA AMPLIFICATION | ASURAGEN, INC. | 2022-06-09 | — | — | US | claimed |
| US-11236384-B2 | Methods of RNA amplification | ASURAGEN, INC. (US) | 2022-02-01 | — | — | US | claimed |
| EP-3914068-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | Spogen Biotech Inc. (US) | 2021-12-01 | — | — | EP | claimed |
| CN-113395898-A | Compositions for treating citrus disease and promoting yield enhancement of row crops | 斯波根生物技术公司 | 2021-09-14 | — | — | CN | claimed |
| US-20200255851-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | GENISYS CREDIT UNION | 2020-08-13 | — | — | US | claimed |
| WO-2020154387-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | SPOGEN BIOTECH INC. (US) | 2020-07-30 | — | — | WO | claimed |
| US-20200140923-A1 | METHODS OF RNA AMPLIFICATION | ASURAGEN, INC. | 2020-05-07 | — | — | US | claimed |
| EP-3606347-A1 | AGRICULTURAL COMPOSITIONS FOR IMPROVED CROP PRODUCTIVITY AND ENHANCED PHENOTYPES | Spogen Biotech Inc. (US) | 2020-02-12 | — | — | EP | claimed |
| US-20180325103-A1 | AGRICULTURAL COMPOSITIONS FOR IMPROVED CROP PRODUCTIVITY AND ENHANCED PHENOTYPES | SPOGEN BIOTECH INC. (US) | 2018-11-15 | — | — | US | claimed |
| WO-2018187345-A1 | AGRICULTURAL COMPOSITIONS FOR IMPROVED CROP PRODUCTIVITY AND ENHANCED PHENOTYPES | SPOGEN BIOTECH INC. (US) | 2018-10-11 | — | — | WO | claimed |
| WO-2018136404-A1 | METHODS OF RNA AMPLIFICATION | ASURAGEN, INC. (US) | 2018-07-26 | — | — | WO | claimed |
| US-20220283149-A1 | ALL-IN-ONE MOLECULAR DIAGNOSTICS DEVICE | GMD BIOTECH, INC (KR) | 2022-09-08 | — | — | US | disclosed |
| US-20220177949-A1 | METHODS OF RNA AMPLIFICATION | ASURAGEN, INC. | 2022-06-09 | — | — | US | disclosed |
| US-11236384-B2 | Methods of RNA amplification | ASURAGEN, INC. (US) | 2022-02-01 | — | — | US | disclosed |
| EP-3914068-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | Spogen Biotech Inc. (US) | 2021-12-01 | — | — | EP | disclosed |
| EP-2396426-A1 | METHOD OF AMPLIFICATION OF GC-RICH DNA TEMPLATES | Asuragen, INC. (US) | 2011-12-21 | — | — | EP | disclosed |
| WO-2010110835-A1 | PCR METHODS FOR CHARACTERIZING THE 5' UNTRANSLATED REGION OF THE FMR1 AND FMR2 GENES | ASURAGEN, INC. (US) | 2010-09-30 | — | — | WO | disclosed |
| US-20100243451-A1 | PCR METHODS FOR CHARACTERIZING THE 5' UNTRANSLATED REGION OF THE FMR1 AND FMR2 GENES | ASURAGEN, INC. | 2010-09-30 | — | — | US | disclosed |
| WO-2010093552-A1 | METHOD OF AMPLIFICATION OF GC-RICH DNA TEMPLATES | ASURAGEN, INC. (US) | 2010-08-19 | — | — | WO | disclosed |
| US-20100209970-A1 | METHOD OF AMPLIFICATION OF GC-RICH DNA TEMPLATES | ASURAGEN, INC. | 2010-08-19 | — | — | US | disclosed |